TARGAN is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries. ALS-S is developing a solution that revolutionizes current vaccination methods. Our technology will detect, target, and deliver vaccines to each and every chick, ensuring effective vaccination. This one-of-a-kind accuracy and consistency in the vaccination process boosts the natural immune response to diseases, improves overall flock health, and provides for a cleaner, healthier chick.
Private Equity Round in 2022
Silicon Ranch Corporation is a developer, owner, and operator of solar energy projects. Their focus is providing excellent customer service while developing cost-effective and creative turnkey solar energy solutions. They work with utilities, military and defense facilities, small to large industrial facilities, and commercial businesses. The company also develops to own all of its projects for the long-term, a distinction that means the company is deeply committed to its partners and communities and stands behind the performance of its facilities day in and day out. Silicon Ranch was founded in 2011 and is based in Nashville, Tennessee, United States.
Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions. The company was founded in 2021 and is headquartered in Albuquerque, New Mexico.
TARGAN is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries. ALS-S is developing a solution that revolutionizes current vaccination methods. Our technology will detect, target, and deliver vaccines to each and every chick, ensuring effective vaccination. This one-of-a-kind accuracy and consistency in the vaccination process boosts the natural immune response to diseases, improves overall flock health, and provides for a cleaner, healthier chick.
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner. It was founded in 2013 and is based in San Francisco, United States.
Advanced Animal Diagnostics, Inc. commercializes proprietary technology for the diagnosis of farm-animal diseases. It uses an animal's own immune response to detect and stage infections to improve the quality of life for producers, processors, animals, and consumers. The company offers QuickSmear, a rapid differential slide to speed and simplify production animal research using differential cell counts; and the SCC+ System for early detection of mastitis. Advanced Animal Diagnostics was founded in 2001 and is based in Durham, North Carolina.
Silicon Ranch Corporation is a developer, owner, and operator of solar energy projects. Their focus is providing excellent customer service while developing cost-effective and creative turnkey solar energy solutions. They work with utilities, military and defense facilities, small to large industrial facilities, and commercial businesses. The company also develops to own all of its projects for the long-term, a distinction that means the company is deeply committed to its partners and communities and stands behind the performance of its facilities day in and day out. Silicon Ranch was founded in 2011 and is based in Nashville, Tennessee, United States.
AN2 Therapeutics, Inc. is a California-based global health biopharmaceutical company focused on modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. The company was founded in 2017 and is headquartered in Menlo Park, California, United States.
TARGAN is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries. ALS-S is developing a solution that revolutionizes current vaccination methods. Our technology will detect, target, and deliver vaccines to each and every chick, ensuring effective vaccination. This one-of-a-kind accuracy and consistency in the vaccination process boosts the natural immune response to diseases, improves overall flock health, and provides for a cleaner, healthier chick.
PhaseBio is a clinical-stage biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. The company uses its proprietary recombinant biopolymers called elastin-like polypeptides (ELPs) to improve the stability, bioavailability, activity, and ease of administration of proteins and peptides, with the goal of achieving greater potency, fewer side effects, and better patient compliance. Efficient production in E. coli ensures a low cost of goods. PhaseBio’s lead drug candidate, PB1023, is currently being evaluated in a phase 2b clinical trial for the treatment of hyperglycemia associated with type 2 diabetes, with potential for future use in the treatment of obesity. Our second drug candidate, Vasomera, is currently being evaluated in phase 1 clinical trial and has exciting potential for use in the treatment of pulmonary arterial hypertension (PAH) and heart failure. Its third program, Insumera, basal insulin based on native human insulin, will enter clinical trials in early 2013. PhaseBio is based in Malvern, Pennsylvania.
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications. It was founded in 2014 and is based in Boston, Massachusetts.
NeuroTronik
Series B in 2017
NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,
Boragen develops synthetic chemistry platforms designed to produce next-generation fungicides. The platform supports sustainable farming methods by creating a compound that decreases the probability of fungicide resistance and reduces the amount of chemical applied while maintaining performance and efficacy. The company utilizes boron’s unique properties to design and develop novel solutions targeting needs in crop protection, animal health, and human health. Founded in 2015, Boragen is based in Durham, North Carolina.
G1 Therapeutics, Inc. is a commercial-stage oncology firm focused on the research and marketing of next-generation anticancer treatments.
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications. It was founded in 2014 and is based in Boston, Massachusetts.
splitsecnd is the only portable and effective portable plug-in vehicle connectivity device on the market. Designed to simply plug into the 12V lighter outlet in any car, splitsecnd can detect a crash, connect you to a live operator, send help to your location, and notify your emergency contact in an instant. Perfect for seniors, teens, and drivers of all ages, splitsecnd uses airbag sensor technology to activate the emergency response system on impact, calling for help even if you can’t respond; it can also be activated manually in the event of a 9-1-1 emergency or roadside breakdown. And with comprehensive trip analytics and GPS capabilities, splitsecnd lets you track routes, encourage good driving habits and even find your parked car. splitsecnd keeps up with you and your family on the road no matter where you are, what you drive, or what the situation. No cell phone required.
MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.
Restore Medical Solutions is a medical device company focusing on products and techniques that promote SSI reduction, safety, and productivity within healthcare. The company manufactures a sterilization tray system that reduces the risk of infection from contaminated medical instruments. Its modular sterilization tray systems reduce the potential risk of infection from contaminated instruments and enable surgical departments to improve the quality of care while reducing cost. Founded in 2012, Restore Medical Solutions is headquartered in Memphis, Tennessee.
Myomo, a medical technology company, develops Myoelectric prosthetic technology to powered bracing devices that restore an individual’s mobility. It offers Myomo mPower 1000, a portable lightweight functional arm brace for use in the home and in clinical settings, which restores movement to a weakened arm as a result of neuromuscular damage caused or due to brain injury, including stroke, spinal cord injury, multiple sclerosis, cerebral palsy, muscular dystrophy, and traumatic brain injury. The company also provides PERL (Push, Eat, Reach, Lift) technique, a set of research-based treatment plans that integrate the mPower 1000 into functional repetitive task practice programs aiming to increase the functional activity; myGames, a virtual reality-based therapeutic training system to encourage brain-injured patients with upper limb motor disorders to practice physical exercises; and myProgress, an Android-based connected health platform that tracks and measures progress while using the mPower 1000. Its mobility system is designed to enable individuals to self-initiate and control the movement of partially paralyzed limbs using their own muscle signals. The company serves medical professionals, patients, and caregivers in the United States. Myomo, Inc. was formerly known as Active Joint Brace. The company was founded in 2004 and is based in Cambridge, Massachusetts.
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents. NuSirts first product, NS-0100, uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies.
Contego Medical has developed a family of novel embolic protection devices. Its portfolio of integrated, multi-functional products is designed to improve patient outcomes and procedural efficiency during revascularization treatment for carotid artery disease, peripheral artery disease, and deep vein thrombosis. The company has FDA clearance for the Paladin Carotid PTA Balloon System with Integrated Embolic Protection, the Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection, and the Excipio SV Thrombectomy Device.
G1 Therapeutics, Inc. is a commercial-stage oncology firm focused on the research and marketing of next-generation anticancer treatments.
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications. It was founded in 2014 and is based in Boston, Massachusetts.
Lineagen is a provider of diagnostic and healthcare services focused on complex diseases for which an individual's genetic profiles contribute strongly to their susceptibility. Lineagen is committed to improving outcomes for those affected by autism and other complex diseases, for which effective early diagnosis and intervention can have a significant positive impact. The company's comprehensive genetic testing and support/counseling service are initially designed to enable early evaluation of children at risk for disorders of childhood development, including autism spectrum disorders (ASDs). Founded in 2002, Lineagen's commercial strategy represents the culmination of significant proprietary research into genetic causes and diagnostic pathways of key complex diseases, including autism, MS, and COPD. One of the company's core research competitive advantages is its access through the University of Utah to the Utah Population Database, an unmatched biomarker discovery research platform that has been used to help the University identify more disease-related genes than any other institution in the world.
Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as the retina, trabecular meshwork, and corneal stroma. The company’s CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.
MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.
Castle Biosciences is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer. The company also focused on providing physicians and patients with personalized, clinically actionable genomic information to make more accurate treatment plan decisions. The DecisionDx family of molecular diagnostic tests have the ability to meaningfully impact how cancers are diagnosed and managed and the DecisionDx-Melanoma predicts risk of recurrence or metastasis for patients with invasive cutaneous melanoma, a deadly skin cancer, including the risk of sentinel lymph node positivity. Castle Biosciences was founded in 2008 and is headquartered in Friendswood, Texas, United States.
InvisionHeart draws on the strengths of experienced leadership, robust software and hardware developers and a strong clinical advisory team. The technology was originally developed by a team of physicians and engineers at Vanderbilt University in response to real-world clinical problems. Along with their team of investors, they share a vision for the improved care of heart patients wherever they live and work.
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents. NuSirts first product, NS-0100, uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies.
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents. NuSirts first product, NS-0100, uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies.
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.
G1 Therapeutics, Inc. is a commercial-stage oncology firm focused on the research and marketing of next-generation anticancer treatments.
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.
Streamweaver is a software company located in Nashville, Tenn. The company's first product is a multi-angle mobile video app that automatically connects people to record together and then generates split-screen video.
SwingPal is a proprietary online golf lesson platform that connects golfers and instructors over the web and via mobile devices. Users record their swings with a smart phone, upload their videos instantly to a SwingPal account, and receive detailed and annotated video and audio analysis from a golf pro, as well as additional instructional videos.
ABT Molecular Imaging, based in Knoxville, Tennessee, specializes in medical imaging by designing, manufacturing, and marketing biomarker generator systems and related accessories. The company’s flagship product, the BG-75 Biomarker Generator, produces unit doses of molecular imaging drugs for positron emission tomography (PET) at the point of use, allowing for on-demand generation of PET biomarkers and radioisotopes. This innovative platform incorporates quality control tests and maintains dose records for each generated dose, ensuring high standards in medical imaging. Founded in 2006 by industry experts Ron and Lynda Nutt, ABT Molecular Imaging distributes its products through a global network of sales and service partners.
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
American Hometown Media (AHM) is a new company with roots stemming from analog publishing. Based in Franklin, Tenn., AHM utilizes similar DNA as traditional media companies such as Publishing Group of America (PGOA) and American Hometown Publishing (AHP), all of which were conceived and founded by Dan Hammond. Now, these roots have been transferred to the digital world with AHM, establishing an internet platform to feature everyday American home cooks as the celebrity. Putting the spotlight on these unsung heroes is the "secret sauce" that is propelling this new digital offering. Although a technology company, AHM hasn't abandoned its analog roots. Utilizing its newspaper & magazine lineage, AHM is also a large syndicator of editorial content featuring journalism celebrating hometown cooks to community newspapers, magazines and other media around the country. Currently some two million households receive the AHM syndicated columns weekly.
SwingPal is a proprietary online golf lesson platform that connects golfers and instructors over the web and via mobile devices. Users record their swings with a smart phone, upload their videos instantly to a SwingPal account, and receive detailed and annotated video and audio analysis from a golf pro, as well as additional instructional videos.
Streamweaver is a software company located in Nashville, Tenn. The company's first product is a multi-angle mobile video app that automatically connects people to record together and then generates split-screen video.
ABT Molecular Imaging, based in Knoxville, Tennessee, specializes in medical imaging by designing, manufacturing, and marketing biomarker generator systems and related accessories. The company’s flagship product, the BG-75 Biomarker Generator, produces unit doses of molecular imaging drugs for positron emission tomography (PET) at the point of use, allowing for on-demand generation of PET biomarkers and radioisotopes. This innovative platform incorporates quality control tests and maintains dose records for each generated dose, ensuring high standards in medical imaging. Founded in 2006 by industry experts Ron and Lynda Nutt, ABT Molecular Imaging distributes its products through a global network of sales and service partners.
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.
Streamweaver is a software company located in Nashville, Tenn. The company's first product is a multi-angle mobile video app that automatically connects people to record together and then generates split-screen video.
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents. NuSirts first product, NS-0100, uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies.
MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
SwingPal is a proprietary online golf lesson platform that connects golfers and instructors over the web and via mobile devices. Users record their swings with a smart phone, upload their videos instantly to a SwingPal account, and receive detailed and annotated video and audio analysis from a golf pro, as well as additional instructional videos.
Diabetes Care Group provides a highly specialized interdisciplinary model of care for individuals with diabetes. Their model integrates state-of-the-art medical management, patient education, and behavioral modification to improve patient self-management and clinical outcomes, while reducing the overall medical and social costs of diabetes. Their integrated approach, built on more than ten years of research and clinical experience, has a track record of getting results for individuals with diabetes. Their program offers an innovative, interdisciplinary approach to diabetes care that has delivered significant, sustained, and documented improvements in outcomes among the most challenging diabetes patients. At Diabetes Care Group, an experienced team, including board certified physicians, registered nurse educators, registered dieticians, and medical assistants, is dedicated to improving your health and quality of life.
Originally founded in 1985 as a healthcare strategic planning consulting firm called m21partners, onFocus Healthcare was re-incorporated in 2008 as a business execution software solutions company. Today, onFocus is the leading provider of enterprise performance management (EPM) software and support services for the healthcare marketplace. Their product, onFocus epm™, ensures that patients get better, faster, and less expensive care by helping hospitals continuously execute and perform at higher levels. They are dedicated to the success of healthcare organizations and the executives, managers and employees who lead them. Through the use of their software products and advisory services, they strive to improve the execution success and performance of every provider they work with by at least 20%.
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.
The founder, Richard Nixdorf, of ICS has over 40 years of experience in developing new ceramic, metal and polymer materials. He has started a number of companies to commercialize various industrial applications of these materials. The fields of use include nuclear reactors, structural composite materials, machine tools, automotive components and others. In the late 1980’s he developed and patented a silicon carbide fiber that had an exceptional property of rapidly converting microwave energy to thermal energy. “Rapidly” means heating to over 1,000oC in 9 seconds in a common kitchen microwave oven. A potential application evolved with the US Clean Air Act requirement to install particulate filters on diesel engine exhaust by 2007. These filters required in-situ, high temperature cleaning on the diesel vehicle. Therefore, materials of composition must be ceramic or special metals. Industrial Ceramic Solutions, LLC (ICS) was founded in 1997 for the purpose of developing and commercializing a microwave regenerated diesel particulate filter (DPF), using the special silicon carbide fibers. Several million dollars in funding was invested by the US Department of Energy and several diesel engine manufacturers. As 2007 moved closer, ICS had developed an excellent ceramic fiber diesel particulate filter cartridge. However, the use of microwave energy proved to be unworkable. Significant worldwide interest in the ICS DPF cartridge and its ability to be regenerated by other acceptable heat sources caught the interest of several international Tier I automotive suppliers. In 2007, a Fortune 100 company signed an exclusive worldwide license to manufacture and sell the ICS DPF. This license agreement came to an end in 2008 with the depression of the diesel engine market through 2011.
Panopto helps businesses and universities create searchable video libraries of their institutional knowledge. Since 2007, the company has been a pioneer in video capture software, video content management systems, and inside-video search technology. Today, Panopto’s video platform is the largest repository of expert learning videos in the world. Headquartered in Seattle with offices in Pittsburgh, London, Hong Kong, Beijing, and Sydney, Panopto has received industry recognition for its innovation, rapid growth, and company culture.
Originally founded in 1985 as a healthcare strategic planning consulting firm called m21partners, onFocus Healthcare was re-incorporated in 2008 as a business execution software solutions company. Today, onFocus is the leading provider of enterprise performance management (EPM) software and support services for the healthcare marketplace. Their product, onFocus epm™, ensures that patients get better, faster, and less expensive care by helping hospitals continuously execute and perform at higher levels. They are dedicated to the success of healthcare organizations and the executives, managers and employees who lead them. Through the use of their software products and advisory services, they strive to improve the execution success and performance of every provider they work with by at least 20%.